Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominic Magirr

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
Plos One|February 11, 2016
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival TrialsDominic Magirr, Thomas Jaki, Franz Koenig, et al.
Pharmaceutical Statistics|May 6, 2024
Visualizing hypothesis tests in survival analysis under anticipated delayed effectsJosé L Jiménez, Isobel Barrott, Francesca Gasperoni, et al.
Statistical Methods in Medical Research|April 1, 2020
Optimized multiple testing procedures for nested sub-populations based on a continuous biomarkerAlexandra Christine Graf, Dominic Magirr, Alex Dmitrienko, et al.
Trials|November 18, 2015
Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-upsAnnabel Allison, Tansy Edwards, Raymond Omollo, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2019
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignanciesAlexander MacDonald, Graeme Scarfe, Dominic Magirr, et al.
British Journal of Haematology|August 22, 2014
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot studySophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Plos One|February 11, 2016
Sample Size Reassessment and Hypothesis Testing in Adaptive Survival TrialsDominic Magirr, Thomas Jaki, Franz Koenig, et al.
Pharmaceutical Statistics|May 6, 2024
Visualizing hypothesis tests in survival analysis under anticipated delayed effectsJosé L Jiménez, Isobel Barrott, Francesca Gasperoni, et al.
Statistical Methods in Medical Research|April 1, 2020
Optimized multiple testing procedures for nested sub-populations based on a continuous biomarkerAlexandra Christine Graf, Dominic Magirr, Alex Dmitrienko, et al.
Trials|November 18, 2015
Generalizing boundaries for triangular designs, and efficacy estimation at extended follow-upsAnnabel Allison, Tansy Edwards, Raymond Omollo, et al.
Cancer Chemotherapy and Pharmacology|February 14, 2019
Phase I study of orally administered <sup>14</sup>Carbon-isotope labelled-vistusertib (AZD2014), a dual TORC1/2 kinase inhibitor, to assess the absorption, metabolism, excretion, and pharmacokinetics in patients with advanced solid malignanciesAlexander MacDonald, Graeme Scarfe, Dominic Magirr, et al.
British Journal of Haematology|August 22, 2014
Influence of proton pump inhibitors and VKORC1 mutations on CYP2C9-mediated dose requirements of vitamin K antagonist therapy: a pilot studySophie Brunner-Ziegler, Bernd Jilma, Dominic Magirr, et al.
BMC Medical Research Methodology|August 15, 2022
On model-based time trend adjustments in platform trials with non-concurrent controlsMarta Bofill Roig, Pavla Krotka, Carl-Fredrik Burman, et al.
Pageof 2